Just my musings ,but it makes sense to me that the company may want to strike a deal re a partnership at the commencement of the ph3 trial,rather than part way through,hence the time passed approx 3 months ,since ph2 trial completion ,from what I can gather ,there’s been no change to trial completion in May.Here’s hoping there in the process of speaking with and or finalising partnership negotiations with a possible suitor.Along with holding talks with the regulators,EMA and FDA.
DYOR
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $350.4M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $147.8K | 610.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 418313 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 362386 | 19 |
View Market Depth
| Last trade - 14.58pm 15/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |